Esoteric Testing Market Share

  • Report ID: 3832
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Esoteric Testing Market Share

North American Market Forecast   

The North American esoteric testing market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2037. The growth of the market can be attributed majorly to the well-established medical infrastructure, and high healthcare spending in the region. As per the data provided by the Centers for Medicare and Medicaid Services, healthcare spending in the United States grew 9.7% in 2020, reaching a value of USD 4.1 trillion or USD 12,530 per person. In addition to this, the increasing frequency of chronic disorders, coupled with the growing ratio of diagnostic tests, as well as the vast population base of aged people are also estimated to fuel the regional market growth further over the forecast period. Furthermore, the escalating proportion of rare disorders, along with the surging investment in R&D activities for rare diseases is also anticipated to accelerate the growth of the esoteric testing market in the region during the projected time frame.

Europe Market Forecast

The European esoteric testing market, amongst the market in all the other regions, is projected to grow with a notable CAGR during the forecast period. The growth of the market can be attributed majorly to the rising utilization of rapid diagnosis, followed by the technological advancements to develop enhanced precision medicine in the region.

Research Nester
Esoteric Testing Market growth
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3832
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of esoteric testing is assessed at USD 30.29 billion.

The esoteric testing market size was valued at USD 27.62 billion in 2024 and is expected to reach USD 122.04 billion by the end of 2037, expanding at around 12.1% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of chronic and infectious diseases, coupled with the rising occurrence of rare disorders will boost the market growth.

North America is likely to dominate majority industry share by 2037, attributed to well-established medical infrastructure, and high healthcare spending in the region.

The major players in the market include H.U. Group Holdings, Inc., Laboratory Corporation of America Holdings, Quest Diagnostics, Healius Limited, Sonic Healthcare Limited, Thyrocare Technologies Limited, Fulgent Genetics, Inc., Kindstar Globalgene Technology, Inc., OPKO Health, Inc., ARUP Laboratories.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample